Suppr超能文献

探索移动医疗改善肾功能的潜力:对不同成年人糖尿病自我护理的随机试验的二次分析。

Exploring mHealth potential to improve kidney function: secondary analysis of a randomized trial of diabetes self-care in diverse adults.

机构信息

Quality Scholars, VA Tennessee Valley Healthcare System, Nashville, TN, USA.

Division of General Internal Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

BMC Nephrol. 2022 Aug 10;23(1):280. doi: 10.1186/s12882-022-02885-6.

Abstract

BACKGROUND

Many individuals living with chronic kidney disease (CKD) have comorbid Type 2 diabetes (T2D). We sought to explore if efficacious interventions that improve glycemic control may also have potential to reduce CKD progression.

METHODS

REACH is a text message-delivered self-management support intervention, which focused on medication adherence, diet, and exercise that significantly improved glycemic control in N = 506 patients with T2D. Using data from the trial, we characterized kidney health in the full sample and explored the intervention's effect on change in estimated glomerular filtration rate (eGFR) at 12 months in a subsample of N=271 patients with eGFR data.

RESULTS

In a diverse sample with respect to race/ethnicity and socioeconomic status, 37.2% had presence of mild or heavy proteinuria and/or an eGFR < 60 mL/min/1.73 m. There was a trending interaction effect between intervention and presence of proteinuria at baseline (b = 6.016, p = .099) such that patients with proteinuria at baseline who received REACH had less worsening of eGFR.

CONCLUSIONS

Future research should examine whether diabetes directed self-management support reduces CKD progression in ethnically diverse individuals with albuminuria. In highly comorbid populations, such as T2D and CKD, text-based support can be further tailored according to individuals' multimorbid disease self-management needs and is readily scalable for individuals with limited resources.

TRIAL REGISTRATION

This study was registered with ClinicalTrials.gov ( NCT02409329 ).

摘要

背景

许多患有慢性肾脏病(CKD)的患者合并有 2 型糖尿病(T2D)。我们试图探索是否有效的干预措施可以改善血糖控制,同时也有可能减缓 CKD 的进展。

方法

REACH 是一种通过短信传递的自我管理支持干预措施,重点关注药物依从性、饮食和运动,该措施显著改善了 506 名 T2D 患者的血糖控制。利用试验数据,我们在全样本中描述了肾脏健康状况,并在 271 名有 eGFR 数据的患者亚组中探索了干预措施对 12 个月时估计肾小球滤过率(eGFR)变化的影响。

结果

在一个种族/民族和社会经济地位多样化的样本中,37.2%的患者有轻度或重度蛋白尿和/或 eGFR<60mL/min/1.73m。干预和基线时蛋白尿的存在之间存在趋势性交互作用(b=6.016,p=0.099),即基线时存在蛋白尿的患者接受 REACH 治疗后,eGFR 的恶化程度较低。

结论

未来的研究应检验糖尿病定向自我管理支持是否可以减少白蛋白尿的 T2D 患者的 CKD 进展。在 T2D 和 CKD 等高度合并症的人群中,基于短信的支持可以根据个体的多种疾病自我管理需求进一步定制,并且易于扩展到资源有限的个体。

试验注册

本研究在 ClinicalTrials.gov 上注册(NCT02409329)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b680/9364602/28d380825994/12882_2022_2885_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验